Moreover, variants in RASGRP1 (Ras guanyl-releasing protein 1), a RAS activator, increase susceptibility to SLE [43], and excessive activation of the RAS/MAPK pathway has been observed in renal tissue from patients with LN [44]. This evidence concerns the gene RASGRP1 and lobular neoplasia.